It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
MONTREAL, Dec. 13 (UPI) -- A McGill University study suggests a new anti-depressant drug works by raising levels of endocannabinoids -- similar to a substance found in marijuana.
The study suggests the new drug, called URB597, might represent a safer alternative to use of marijuana for treatment of pain and depression, and open the door to new and improved treatments for clinical depression.
In pre-clinical laboratory tests researchers found URB597 increased the production of endocannabinoids by blocking their degradation, resulting in measurable antidepressant effects.